- Home
- OBIO vs NNBR Comparison
OBIO vs NNBR Comparison
Compare OBIO & NNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- NNBR
- Stock Information
- Founded
- OBIO 2017
- NNBR 1980
- Country
- OBIO United States
- NNBR United States
- Employees
- OBIO N/A
- NNBR N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- NNBR Industrial Machinery/Components
- Sector
- OBIO Health Care
- NNBR Industrials
- Exchange
- OBIO Nasdaq
- NNBR Nasdaq
- Market Cap
- OBIO 151.3M
- NNBR 149.8M
- IPO Year
- OBIO N/A
- NNBR 1994
- Fundamental
- Price
- OBIO $4.28
- NNBR $2.26
- Analyst Decision
- OBIO Strong Buy
- NNBR
- Analyst Count
- OBIO 5
- NNBR 0
- Target Price
- OBIO $15.40
- NNBR N/A
- AVG Volume (30 Days)
- OBIO 51.3K
- NNBR 156.2K
- Earning Date
- OBIO 05-12-2025
- NNBR 03-05-2025
- Dividend Yield
- OBIO N/A
- NNBR N/A
- EPS Growth
- OBIO N/A
- NNBR N/A
- EPS
- OBIO N/A
- NNBR N/A
- Revenue
- OBIO $2,647,000.00
- NNBR $464,290,000.00
- Revenue This Year
- OBIO $22.61
- NNBR $3.17
- Revenue Next Year
- OBIO $16.64
- NNBR $5.90
- P/E Ratio
- OBIO N/A
- NNBR N/A
- Revenue Growth
- OBIO N/A
- NNBR N/A
- 52 Week Low
- OBIO $3.75
- NNBR $2.25
- 52 Week High
- OBIO $8.87
- NNBR $4.86
- Technical
- Relative Strength Index (RSI)
- OBIO 45.19
- NNBR 31.26
- Support Level
- OBIO $4.14
- NNBR $2.38
- Resistance Level
- OBIO $4.67
- NNBR $2.67
- Average True Range (ATR)
- OBIO 0.34
- NNBR 0.14
- MACD
- OBIO 0.06
- NNBR -0.01
- Stochastic Oscillator
- OBIO 51.70
- NNBR 2.27
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About NNBR NN Inc.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets. It also operates in China, Mexico, Brazil, Germany, and other countries.